Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
暂无分享,去创建一个
S. Richards | A. Vora | O. Eden | G. Harrison | C. Harrison | B. Gibson | F. Hill | I. Hann
[1] A. Vora,et al. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials , 2000, Leukemia.
[2] F. Behm,et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] T. Golub,et al. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. , 1998, Blood.
[4] M. Kami,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[5] G. Gustafsson,et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non‐high‐risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996 , 1998, Acta paediatrica.
[6] N. Heerema,et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies , 1998, Cancer.
[7] A. Baruchel,et al. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables , 1998, British journal of haematology.
[8] O. Eden,et al. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI) , 1998, Leukemia.
[9] H. Sather,et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. , 1998, The New England journal of medicine.
[10] J. Harbott,et al. Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials , 1998, Leukemia.
[11] H. Prentice,et al. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties , 1998, Leukemia.
[12] H. Adams,et al. TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia , 1998 .
[13] Elaine Coustan-Smith,et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia , 1998, The Lancet.
[14] N. Heerema,et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Borkhardt,et al. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. , 1997, Blood.
[16] H. Sather,et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia , 1997, Cancer.
[17] S. Richards,et al. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X , 1997, British journal of haematology.
[18] F. Mitelman,et al. Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986‐91 , 1997, Acta paediatrica.
[19] Maria Grazia Valsecchi,et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials , 1997 .
[20] S. Richards,et al. Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin , 1997, British journal of haematology.
[21] J. Downing,et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Downing,et al. Non-Hodgkin's lymphoma in childhood. , 1996, The New England journal of medicine.
[23] H. Sather,et al. Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C C Bailey,et al. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials * , 1995, British journal of haematology.
[25] C. C. Bailey,et al. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X , 1995, The Lancet.
[26] B. Horizonte,et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. , 1994, Archives of disease in childhood.
[27] A. Morley,et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction , 1994, The Lancet.
[28] G. Reaman,et al. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] H. Sather,et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] F. Behm,et al. Hyperdiploid (47-50) acute lymphoblastic leukemia in children. , 1992, Blood.
[31] O. Eden,et al. Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients , 1992, British journal of haematology.
[32] F. Behm,et al. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. , 1990, Blood.
[33] H. Sather,et al. Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Ritter,et al. Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83) , 1987 .
[35] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[36] P S Gaynon,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group , 2016 .
[37] N. Heerema,et al. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. , 1999, Leukemia & lymphoma.
[38] H. Adams,et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group. , 1998, Blood.
[39] C. Pui,et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Y. Komada,et al. Improved therapy for children with acute lymphoblastic leukemia. , 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[41] L. Frankel,et al. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. , 1992, Leukemia.
[42] G. Henze,et al. Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia. , 1990, Haematology and blood transfusion.
[43] F. Berthold,et al. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]. , 1987, Klinische Padiatrie.